Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury - PubMed (original) (raw)
Review
. 1987 May 15;46(7):2422-33.
- PMID: 3106093
Review
Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury
K M Mullane et al. Fed Proc. 1987.
Abstract
Within minutes of occlusion of a major coronary artery the polymorphonuclear leukocytes (PMNs) are activated whereby they adhere to the vascular endothelium and migrate through the endothelial layer. Interactions with the endothelium can promote increased vascular resistance, diminished collateral flow, capillary blockade, and predisposition to vasospasm, as well as enhanced vascular permeability. On subsequent reperfusion entrapped leukocytes contribute to the no-reflow phenomenon, while more leukocytes gain access to the previously ischemic region. The leukocytes infiltrate the myocardium where they exacerbate the process of tissue injury and the development of arrhythmias. The release of leukocyte-derived mediators including arachidonic acid (AA) metabolites and oxygen-derived free radicals probably underlies these activities of the leukocytes. PMNs contain active lipoxygenase enzymes capable of metabolizing AA to products that are not normally found in the myocardium, and can dominate the metabolic profile of that tissue, leading to changes in myocardial integrity and function. Inhibitors of the lipoxygenase enzymes suppress the accumulation of leukocytes into the ischemic myocardium and reduce infarct size. However, because the drugs prevent cell invasion it cannot be inferred that a lipoxygenase metabolite per se is deleterious to the ischemic heart, inasmuch as any leukocyte-dependent mechanism of injury will be attenuated whether it is mediated by eicosanoids or by any other leukocyte-derived product. Additional studies with specific inhibitors/antagonists are required to determine the biochemical mechanisms underlying the different aspects of leukocyte-mediated myocardial injury.
Similar articles
- Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs.
Mullane KM, Read N, Salmon JA, Moncada S. Mullane KM, et al. J Pharmacol Exp Ther. 1984 Feb;228(2):510-22. J Pharmacol Exp Ther. 1984. PMID: 6420544 - Eicosanoids in myocardial ischemia.
Schrör K, Thiemermann C. Schrör K, et al. Biomed Biochim Acta. 1989;48(10):729-34. Biomed Biochim Acta. 1989. PMID: 2517526 Review. - [The role of the granulocytes in ischemic cardiopathy].
Mazzone A, Pasotti D, Mazzucchelli I, Fossati G, Ricevuti G. Mazzone A, et al. Recenti Prog Med. 1994 Jul-Aug;85(7-8):397-406. Recenti Prog Med. 1994. PMID: 8079042 Review. Italian. - Effects of leukocyte activation on myocardial vascular resistance.
Ito BR, Schmid-Schönbein G, Engler RL. Ito BR, et al. Blood Cells. 1990;16(1):145-63; discussion 163-6. Blood Cells. 1990. PMID: 2112413 Review. - Regulation of coronary blood flow during exercise.
Duncker DJ, Bache RJ. Duncker DJ, et al. Physiol Rev. 2008 Jul;88(3):1009-86. doi: 10.1152/physrev.00045.2006. Physiol Rev. 2008. PMID: 18626066 Review.
Cited by
- Protective effects of calcium antagonists against ischaemia and reperfusion damage.
Ferrari R, Visioli O. Ferrari R, et al. Drugs. 1991;42 Suppl 1:14-26; discussion 26-7. doi: 10.2165/00003495-199100421-00005. Drugs. 1991. PMID: 1718690 Review. - Role of leucocytes in free radical production during myocardial revascularisation.
De Vecchi E, Paroni R, Pala MG, Di Credico G, Agape V, Gobbi C, Bonini PA, Paolini G, Grossi A. De Vecchi E, et al. Heart. 1997 May;77(5):449-55. doi: 10.1136/hrt.77.5.449. Heart. 1997. PMID: 9196416 Free PMC article. Clinical Trial. - Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
Zembowicz A, Hatchett RJ, Jakubowski AM, Gryglewski RJ. Zembowicz A, et al. Br J Pharmacol. 1993 Sep;110(1):151-8. doi: 10.1111/j.1476-5381.1993.tb13785.x. Br J Pharmacol. 1993. PMID: 7693274 Free PMC article. - Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical.
Babbitt DG, Forman MB, Jones R, Bajaj AK, Hoover RL. Babbitt DG, et al. Am J Pathol. 1990 Feb;136(2):451-9. Am J Pathol. 1990. PMID: 2407126 Free PMC article. - Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.
Di Paola R, Cuzzocrea S. Di Paola R, et al. Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):157-75. doi: 10.1007/s00210-007-0141-2. Epub 2007 Mar 13. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17394034 Review.